Large-for-gestational age diagnosed during second-trimester anatomy ultrasound and association with gestational diabetes and large-for-gestational age at birth.
To determine if large for gestational age (LGA) diagnosed during second trimester ultrasound is associated with the development of gestational diabetes mellitus (GDM) and LGA at birth. We performed a retrospective cohort study of all patients who underwent a second trimester anatomy ultrasound between 18 and 22 weeks at our institution from 2012 to 2017. Patients were included in the LGA group if the estimated fetal weight was >90th percentile and/or the fetal abdominal circumference was >90th percentile for gestational age. Patients with a history of pre-GDM, multiple gestation, preterm delivery, use of betamethasone, or fetal anomalies were excluded. The comparative group was selected from a set of appropriate for gestational age (AGA) patients from 18-22 weeks gestational age that were seen during the study period. AGA was defined as an EFW measuring greater than 10th percentile but less than or equal to 89th percentile. Prenatal and delivery records were reviewed and demographic and outcome variables were collected. Multivariable logistic regression models were performed to assess the impact of LGA at second trimester on the development of GDM and LGA at birth. There were 756 LGA and 756 AGA patients included in this study. In patients with LGA diagnosed during second trimester ultrasound, the incidence of GDM was 6% and the incidence of LGA at birth was 14.9%. Among patients with LGA in the second trimester, those who developed GDM or LGA at birth were significantly older, and were more likely to be obese. Moreover, parity was associated with neonatal LGA (P = 0.0003) but not with GDM at birth (P = 0.82). In adjusted analyses, LGA diagnosis during second trimester was significantly associated with GDM (OR 2.54; 95% CI: 1.29, 5.03) and neonatal LGA at birth (OR 6.85, 95% CI 3.60, 13.05; p<0.0001). LGA diagnosis during second trimester ultrasound is associated with the development of GDM and LGA at birth, independent of women with known risk factors, and could be used to identify these women earlier for intervention. This article is protected by copyright. All rights reserved.